Reviva Pharmaceuticals Warrants
RVPHW
RVPHW was delisted on the 12th of December, 2025.
12 hedge funds and large institutions have $607K invested in Reviva Pharmaceuticals Warrants in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$112K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$86.6K |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$80.2K |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$80.2K |
| 5 |
6CM
683 Capital Management
New York
|
+$64.2K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
BlueCrest Capital Management
St Helier,
Jersey
| $116K | +$112K | +350,000 | New |
|
|
OAM
2
Oxford Asset Management
Oxford,
United Kingdom
| $89K | +$86.6K | +270,000 | New |
|
|
AA
3
AQR Arbitrage
Greenwich,
Connecticut
| $83K | +$80.2K | +250,000 | New |
|
|
GCL
4
Glazer Capital LLC
New York
| $83K | +$80.2K | +250,000 | New |
|
|
6CM
5
683 Capital Management
New York
| $66K | +$64.2K | +200,000 | New |
|
|
CI
6
Cowen Inc
New York
| $56K | +$54.9K | +171,059 | New |
|
|
PAM
7
Panagora Asset Management
Boston,
Massachusetts
| $38K | +$37.3K | +116,337 | New |
|
|
BCM
8
Bluefin Capital Management
New York
| $28K | +$27.4K | +85,378 | New |
|
|
BI
9
Bulldog Investors
Saddle Brook,
New Jersey
| $18K | +$17.4K | +54,305 | New |
|
|
PAMP
10
Polar Asset Management Partners
Toronto,
Ontario, Canada
| $13K | +$12.8K | +40,000 | New |
|
|
PC
11
Periscope Capital
Toronto,
Ontario, Canada
| $13K | +$12.9K | +40,300 | New |
|
12
Walleye Trading
New York
| $4K | +$3.53K | +11,000 | New |
|
RVPHW Hedge Fund Activity: Q4 2018 in Review
12 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q4 2018, worth a combined $607K.
Buyers outnumbered sellers: 12 funds opened new RVPHW positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BlueCrest Capital Management, opening a new position worth an estimated $112K.
- 12 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q4 2018, up from 0 in Q3 2018.
- Funds reported $607K of Reviva Pharmaceuticals Warrants stock for Q4 2018.
- 12 funds opened new Reviva Pharmaceuticals Warrants positions in Q4 2018 and 0 closed out, a net change of +12 holders.
- The largest Reviva Pharmaceuticals Warrants buyer in Q4 2018 was BlueCrest Capital Management, an estimated $112K added.
Based on aggregated 13F filings for Q4 2018.